From: Identifying biomarkers for breast cancer by gene regulatory network rewiring
GO term | Description | Adjusted P-value | Biomarker |
---|---|---|---|
GO:0031323 | Regulation of cellular metabolic process | 1.90E−30 | NFKB2, DGKZ, JUN, KLF9, RAD51, UHRF1, CDC25A, CCNE1, CDK2, CCNE2, TAF11, PKMYT1, ZBTB4, UBE2S, CDKN2C, KDM4B, BCL2, TCEAL5, NFYA, NR3C1, MAZ, MAFF, CTGF, KLF4, STAT5B, TP73, GATA3, HOXA10, SOX4, BRCA1 |
GO:0060255 | Regulation of macromolecule metabolic process | 7.40E−29 | NFKB2, BAX, JUN, KLF9, RAD51, UHRF1, CCNE1, CDK2, TAF11, ZBTB4, UBE2S, KDM4B, BCL2, TCEAL5, NFYA, NR3C1, MAZ, MAFF, CTGF, KLF4, STAT5B, TP73, GATA3, HOXA10, SOX4, BRCA1 |
GO:0051171 | Regulation of nitrogen compound metabolic process | 4.00E−26 | NFKB2, JUN, KLF9, RAD51, UHRF1, CCNE1, CDK2, TAF11, ZBTB4, KDM4B, TCEAL5, NFYA, NR3C1, MAZ, MAFF, KLF4, STAT5B, TP73, GATA3, HOXA10, SOX4, BRCA1 |
GO:0051726 | Regulation of cell cycle | 3.30E−24 | DGKZ, JUN, CDC25A, CDK2, CCNE2, PKMYT1, CDKN2C, NEK2, TACC3, BCL2, CTGF, STAT5B, TP73, BRCA1 |
GO:0019219 | Regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 8.80E−24 | NFKB2, JUN, KLF9, RAD51, UHRF1, CCNE1, CDK2, TAF11, ZBTB4, KDM4B, TCEAL5, NFYA, NR3C1, MAZ, MAFF, KLF4, STAT5B, TP73, GATA3, HOXA10, SOX4, BRCA1 |
GO:0010604 | Positive Regulation of macromolecule metabolic process | 1.10E−23 | JUN, RAD51, CCNE1, CDK2, TAF11, UBE2S, BCL2, NFYA, CTGF, STAT5B, TP73, SOX4, BRCA1 |
GO:0051173 | Positive regulation of nitrogen compound metabolic process | 2.10E−23 | JUN, RAD51, CCNE1, CDK2, TAF11, NFYA, STAT5B, TP73, SOX4, BRCA1 |
GO:0009893 | Positive regulation of metabolic process | 2.40E−23 | JUN, RAD51, CCNE1, CDK2, TAF11, UBE2S, BCL2, NFYA, CTGF, STAT5B, TP73, SOX4, BRCA1 |
GO:0006357 | Regulation of Transcription from RNA polymerase II promoter | 1.00E−16 | JUN, KLF9, UHRF1, NFYA, STAT5B, BRCA1 |
GO:0042127 | Regulation of cell proliferation | 1.20E−16 | JUN, CDK2, CDKN2C, BCL2, CTGF, KLF4, STAT5B, SOX4, BRCA1 |
GO:0048545 | Response to steroid hormone stimulus | 5.60E−15 | CCNE1, BCL2, CTGF, STAT5B, GATA3, BRCA1 |
GO:0051716 | Cellular response to stimulus | 1.70E−11 | DGKZ, JUN, RAD51, UHRF1, CCNE1, POLE2, BCL2, PIK3R1, STAT5B, TP73, BRCA1 |
GO:0010941 | Regulation of cell death | 5.10E−10 | BAX, JUN, TUBB, CDKN2C, BCL2, CTGF, STAT5B, TP73, SOX4, BRCA1 |
GO:0043067 | Regulation of programmed cell death | 1.70E−09 | BAX, JUN, TUBB, CDKN2C, BCL2, CTGF, STAT5B, TP73, SOX4, BRCA1 |
GO:0042325 | Regulation of Phosphorylation | 6.80E−09 | DGKZ, JUN, CDC25A, CCNE2, PKMYT1, CDKN2C, BCL2, CTGF, TP73 |
GO:0007346 | Regulation of mitotic cell cycle | 7.00E−09 | DGKZ, CDK2, PKMYT1, NEK2, BCL2, STAT5B |
GO:0051094 | Positive regulation of developmental process | 1.20E−08 | BAX, JUN, CCNE1, BCL2, STAT5B |
GO:0006974 | Response to DNA damage stimulus | 5.20E−07 | DGKZ, RAD51, UHRF1, POLE2, TP73, BRCA1 |
GO:0000075 | Cell cycle checkpoint | 2.00E−06 | DGKZ, CCNE2, BRCA1 |
GO:0045786 | Negative regulation of cell cycle | 2.60E−06 | DGKZ, CDKN2C, BCL2, TP73 |
GO:0030522 | Intracellular receptor mediated signaling pathway | 2.90E−06 | KLF9, CCNE1, BRCA1 |
GO:0048729 | Tissue morphogenesis | 4.00E−05 | BCL2 |
GO:0030217 | T cell differentiation | 8.10E−05 | BCL2, STAT5B, SOX4 |
GO:0002009 | Morphogenesis of an epithelium | 1.50E−04 | BCL2 |
GO:0030098 | Lymphocyte differentiation | 8.90E−04 | BCL2, STAT5B, SOX4 |